BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23590138)

  • 1. Roles and therapeutic potential of metallothioneins in neurodegenerative diseases.
    Hozumi I
    Curr Pharm Biotechnol; 2013; 14(4):408-13. PubMed ID: 23590138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian Metallothionein-3: New Functional and Structural Insights.
    Vašák M; Meloni G
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches.
    Bolognin S; Cozzi B; Zambenedetti P; Zatta P
    J Alzheimers Dis; 2014; 41(1):29-42. PubMed ID: 24577478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the metallothionein family of proteins in the central nervous system.
    Hidalgo J; Aschner M; Zatta P; Vasák M
    Brain Res Bull; 2001 May; 55(2):133-45. PubMed ID: 11470309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.
    Hozumi I; Hasegawa T; Honda A; Ozawa K; Hayashi Y; Hashimoto K; Yamada M; Koumura A; Sakurai T; Kimura A; Tanaka Y; Satoh M; Inuzuka T
    J Neurol Sci; 2011 Apr; 303(1-2):95-9. PubMed ID: 21292280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of metallothioneins in aging brain.
    Sharma S; Ebadi M
    Neurochem Int; 2014 Jan; 65():40-8. PubMed ID: 24389356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of Cu(I) and Zn(II) sites in neuronal-growth-inhibitory factor by extended X-ray absorption fine structure (EXAFS).
    Bogumil R; Faller P; Binz PA; Vasák M; Charnock JM; Garner CD
    Eur J Biochem; 1998 Jul; 255(1):172-7. PubMed ID: 9692916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis.
    Ono SI
    Curr Pharm Des; 2017; 23(33):5001-5009. PubMed ID: 28641540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox labile site in a Zn4 cluster of Cu4,Zn4-metallothionein-3.
    Roschitzki B; Vasák M
    Biochemistry; 2003 Aug; 42(32):9822-8. PubMed ID: 12911326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative renal toxicity of metallothioneins with different cadmium/zinc ratios in rats.
    Kojima S; Furukawa A; Kiyozumi M; Shimada H
    Toxicol Lett; 1991 Apr; 56(1-2):197-205. PubMed ID: 2017779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.
    Esposito E; Rotilio D; Di Matteo V; Di Giulio C; Cacchio M; Algeri S
    Neurobiol Aging; 2002; 23(5):719-35. PubMed ID: 12392777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
    Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
    Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
    Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis.
    Blaauwgeers HG; Anwar Chand M; van den Berg FM; Vianney de Jong JM; Troost D
    J Neurol Sci; 1996 Oct; 142(1-2):39-44. PubMed ID: 8902718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MT in neurological disorders.
    Aschner M; West AK
    J Alzheimers Dis; 2005 Nov; 8(2):139-45; discussion 209-15. PubMed ID: 16308482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g).
    Sogawa CA; Miyazaki I; Sogawa N; Asanuma M; Ogawa N; Furuta H
    Brain Res; 2000 Jan; 853(2):310-6. PubMed ID: 10640628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo-folded metal-metallothionein 3 complexes reveal the Cu-thionein rather than Zn-thionein character of this brain-specific mammalian metallothionein.
    Artells E; Palacios O; Capdevila M; Atrian S
    FEBS J; 2014 Mar; 281(6):1659-78. PubMed ID: 24479872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-induced mobilization of copper and zinc bound to renal metallothionein in cadmium-loaded rats.
    Suzuki KT; Tamagawa H; Takahashi K; Shimojo N
    Toxicology; 1990 Mar; 60(3):199-210. PubMed ID: 2315941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, circular dichroism, magnetic circular dichroism and emission study of rat kidney Cd,Cu-metallothionein.
    Stillman MJ; Szymanska JA
    Biophys Chem; 1984 Mar; 19(2):163-9. PubMed ID: 17005138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.